Autopsy report · NCT04376567
Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas
Cause of deathStaffing, sites or logistics
“The PI is leaving the institution and the trial will be not resuming.”
Life of this trial
- Registered 1 year 9 months before it started.
- Ran for about 2 years 1 month before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 1 year 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Tze-Woei Tan
- Sponsor type
- University, hospital or other
- Conditions
- End Stage Renal Failure; Hemodialysis Access Failure; Arterio-venous Fistula
- Interventions
- One stage approach
- Participants
- 2
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation
“No subjects have been accrued to this trial. The PI will no longer be at COH and requests a study withdrawal/closure.” - Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
“The PI left the Institution and sponsor decided to close the trial.” - Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
“PI and Sponsor decided to not proceed with the trial.” - PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)
“The study is terminated because the PI left the institution.” - Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
“PI is leaving institution and this protocol will not be further pursued at this institution.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.